Protective effect of ulinastatin on vascular endothelial glycocalyx in pediatric liver transplantation

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044964

Enrollment

Unknown

Registered

2021-04-03

Start date

2021-04-30

Completion date

Unknown

Last updated

2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Interventions

Ulinastatin group:Ulinastatin

Control group:Isometric saline

Eligibility

Sex/Gender

All

Age

1 Years to 5 Years

Inclusion criteria

Inclusion criteria: Select 5-10 months old pediatric liver transplant patients with congenital biliary atresia.

Exclusion criteria

Exclusion criteria: 1. Liver and kidney dysfunction before surgery; 2. Liver transplantation with excluding dead liver donors; 3. A history of surgery before surgery; 4. The duration of surgery is greater than 10 hours; 5. The amount of bleeding during surgery is greater than 500.

Design outcomes

Primary

Measure	Time frame
glycocalyx;	—

Countries

China

Contacts

Public ContactFang Fuquan

The First Affiliated Hospital, Zhejiang University school of Medicine

fuquanf@163.com+86 15158176557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026